Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

5 of Last Week's Biggest Winners

By Rick Munarriz - Jul 13, 2014 at 7:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These five stocks posted double-digit percentage gains.

It was a rough week on Wall Street, with the market moving lower, but there were plenty of stocks still moving higher. Let's take a closer look at five of this past week's biggest scorchers.


July 11

Weekly Gain

Camtek Ltd. ( CAMT -2.58% )



Endeavour Silver ( EXK -3.02% )



Glu Mobile ( GLUU )



TherapeuticsMD ( TXMD -7.54% )



TRW Automotive (NYSE: TRW)



Source: Barron's.

Let's start with Camtek. The stock soared after launching its new Eagle product line that supports the advanced packaging market by offering 2-D and 3-D inspection and metrology capabilities on the same platform. Stocks don't often rally on a mere rollout, but Camtek also announced that it has already received orders from leading device manufacturers. 

Endeavour Silver struck it rich after providing an encouraging production update for the second quarter. Endeavour saw its silver production increase 9% to 1.67 million ounces for the period. That was partly offset by a reduction in white gold production, but the real nugget for the market is that the results find Endeavour trending ahead of guidance year to date. 

Glu Mobile continues to gain momentum since rolling out a new game -- Kim Kardashian: Hollywood -- late last month that is soaring in popularity. Glu Mobile's stock has posted three consecutive weeks of double-digit gains, and it's closed higher for weeks in a row. 

"It might be our biggest game of the year," Glu Mobile's CEO told Bloomberg in an interview this past week. Judging by the stock's pop every week since the new game raced to the near the top of iOS and Android app downloads, it's easy to believe the CEO's comments.

TherapeuticsMD didn't call in sick. The developer of therapies for women bumped higher after FBR Capital initiated coverage with an "outperform" rating at a price target of $34. As a refresher, the stock is trading in the single digits. FBR Capital is encouraged by the biotech's hormone replacement pipeline.  

Finally, we have TRW Automotive revving up after announcing that it has received an unsolicited buyout offer. The interested buyer -- and terms of the offer -- weren't revealed, but some reports indicate that the interest is coming from a rival German auto-parts maker.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Glu Mobile Stock Quote
Glu Mobile
Endeavour Silver Corp. Stock Quote
Endeavour Silver Corp.
$4.17 (-3.02%) $0.13
TherapeuticsMD, Inc. Stock Quote
TherapeuticsMD, Inc.
$0.46 (-7.54%) $0.04
Camtek Ltd. Stock Quote
Camtek Ltd.
$43.40 (-2.58%) $-1.15

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/04/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.